Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 14. November 2026
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 3110  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 62185  
   
DNA Repair Pathways as Determinants of PARP Inhibitor Resistance and Therapeutic Targets in Cancer.
Int J Mol Sci
Lavudi K, Renjith MS, Pithana Sai Venkata Vijay C, Kokkanti RR, Pandey P, Ponneganti S.
PMID: 43028061 [PubMed - indexed for MEDLINE]


Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment.
Int J Mol Sci
Bertalmio N, Marino FAL, Brundu S, Rustichelli S, Giraudo E.
PMID: 43028035 [PubMed - indexed for MEDLINE]


Cancer Risk Linked to Ultra-Processed Foods: Epidemiological Findings, Potential Mechanisms, and Research Outlook.
Foods
Zhao M, Zhang X.
PMID: 43027519 [PubMed]


The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer.
Cancers (Basel)
Smith JP.
PMID: 43026872 [PubMed]


Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990-2023: Evidence from the Global Burden of Disease Study 2023.
Cancers (Basel)
Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, Zheng Y, Liu Y.
PMID: 43026856 [PubMed]


Treatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.
Cancers (Basel)
Turner KM, Gurewitz JB, Frakes JM, Denbo JW, Malafa MP, Hodul PJ, Kim DW, Sinnamon AJ.
PMID: 43026841 [PubMed]


Synergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer.
Cancers (Basel)
Ghosh AK, Jazieh KA, Xie H, Parish MA, Babiker HM, Bekaii-Saab TS, Goenka AH, Knutson KL, Pandey A, Fernandez-Zapico ME, Carr RM, George B.
PMID: 43026840 [PubMed]


Circulating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring.
Cancers (Basel)
Abue M, Asano N, Morikawa T, Masamune A, Nishizuka S, Yasuda J.
PMID: 43026792 [PubMed]


The Association Between Asthma and Pancreatic Cancer: A Systematic Review.
Cancers (Basel)
Darawsha B, Lavu H, Yeo CJ, Hanna N, Nevler A.
PMID: 43026779 [PubMed]


Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Pancreatic Neuroendocrine Neoplasms.
Cancers (Basel)
Jab.
PMID: 43026749 [PubMed]


A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.
HPB (Oxford)
Agritelley ES, Kanu EN, Button J, Bao M, Sannareddy DS, Fletcher AA, Skinner H, Molvin A, Rodgman M, Murray S, Chai J, Niedzwiecki D, DeVito NC, Blobe GC, Strickler JH, Hsu SD, Howard M, Abbruzzese JL, Martin AN, Zani S, Lidsky ME, Kim CY, Suhocki P, Cline B, Johnson D, Crosby EJ, Mettu NB, Mastria E, Allen PJ, Nussbaum DP.
PMID: 43026127 [PubMed - as supplied by publisher]


Impact of Clonal Hematopoiesis on Outcomes in Metastatic Pancreatic Ductal Adenocarcinoma: Analysis From the PASS-01 Trial.
JCO Precis Oncol
Sainamthip P, Somadasan M, Culnane L, Andrews E, Brais L, Andrews M, Jang GH, Zhang A, Wilson JM, Ramotar S, Dodd A, Perez KJ, Yu K, Laheru D, King DA, O'Kane GM, Gallinger S, Tuveson D, Jaffee EM, Knox JJ, Notta F, Aguirre AJ, Wolpin BM, Sperling AS, Singh H.
PMID: 43024846 [PubMed - indexed for MEDLINE]


Pathologic and Molecular Characterization of Branch Duct Intraductal Papillary Mucinous Neoplasm With Advanced Neoplasia Under-Recognized by Kyoto High-Risk Stigmata.
Pancreas
Maloof T, Chen W, Esnakula AK, Frankel WL, Culp S, Abdelbaki A, Hart PA, Machicado JD, Cruz-Monserrate Z, Shah ZK, Pawlik TM, Krishna SG.
PMID: 43024803 [PubMed - as supplied by publisher]


Tumor Treating Fields and Quality of Life Among Patients With Locally Advanced Pancreatic Adenocarcinoma: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
Macarulla T, Picozzi V, Chandana SR, Melichar B, Kasi A, Gang J, Gallego J, de la Fouchardière C, Bullock A, Chunyi H, Wyrwicz L, Osipov A, Dragovich T, Lee W, Feeney K, Philip PA, Ueno M, Van Cutsem E, Seufferlein T, Babiker H, PANOVA-3 study investigators.
PMID: 43024239 [PubMed - indexed for MEDLINE]


Open versus minimally invasive surgery for large type 3 and type 4 gastric cancer: multicentre retrospective national study at high-volume centres.
Br J Surg
Kitadani J, Tokunaga M, Mizusawa J, Yamamoto K, Fujiya K, Nunobe S, Kinoshita T, Sakashita K, Kasahara K, Ishida M, Hamakawa T, Honda M, Sakuramoto S, Yamada T, Hayata K, Hara K, Tanaka R, Yamagata Y, Kawase T, Kurokawa Y, Boku N, Yoshikawa T.
PMID: 43023692 [PubMed - indexed for MEDLINE]


Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions.
Curr Cancer Drug Targets
Ma Y, Wang M, Zhang K, Ren F, Wang Y, Zhang W, Kan C, Han F, Sun H, Sun X.
PMID: 43023373 [PubMed - as supplied by publisher]


Immune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies.
Front Immunol
Gu G, Du Y, Zhang H, Zheng Y, Yao Y, Yan Q.
PMID: 43022561 [PubMed - indexed for MEDLINE]


Comparison of Survival Between Patients with Hepatocellular Carcinoma Beyond the "Up-to-7" Criterion Who Received Adjuvant PD-1 Inhibitors or Active Surveillance: A Target Trial Emulation Study.
J Clin Transl Hepatol
Su JY, Liu Z, Yang TX, Guo PP, Luo M, Liu SP, Dong XF, Xu XL, Chen SC, Ou JJ, Chen K, Li ZC, Su Z, Yang FQ, He WH, Peng N, Wu PS, Long BB, Su H, Huang ML, Li WT, Chen WT, Li JR, Yang DL, Huang ZH, Lin LP, Huo RR, Ma YL, Ma L, Zhong XB, Zhong JH, GUIDANCE investigators.
PMID: 43022106 [PubMed]


Clinical Impact in Pancreatic Cancer Trials: Time to Raise the Bar.
Ann Surg
van Eijck CHJ, Katz MHG, Besselink MG.
PMID: 43021448 [PubMed - as supplied by publisher]


Histopathological findings associated with prognosis in resected ductal adenocarcinoma of the pancreas.
Arq Bras Cir Dig
Soares EV, Toaza E, Cambruzzi E.
PMID: 43017946 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 62185    Seite 1 von 3110  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1